SEC Form 4 · accession 0001232524-15-000122
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen J Wilson
Officer — SVP, Finance & PAO
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jun 1, 2015 | M | 1,500 | $59.13 | A | 27,399 | D | |
| Ordinary Shares | Jun 1, 2015 | S | 1,500 | $179.75 | D | 25,899 | D | |
| Ordinary Shares | Jun 1, 2015 | M | 3,994 | $46.83 | A | 29,893 | D | |
| Ordinary Shares | Jun 1, 2015 | S | 3,994 | $179.50 | D | 25,899 | D | |
| Ordinary Shares | Jun 2, 2015 | S | 257 | $180.00 | D | 25,642 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $46.83 | Jun 1, 2015 | M | 3,994 | D | — | Aug 8, 2022 | Ordinary Shares | 3,994 | 6,708 | D |
| Non-Qualified Stock Option (right to buy)F3 | $59.13 | Jun 1, 2015 | M | 1,500 | D | — | Mar 4, 2023 | Ordinary Shares | 1,500 | 4,750 | D |
Explanation of responses
- F1Includes 257 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2015.
- F2As of the date of this report, the remaining ordinary shares subject to this option will vest with respect to 3,843 shares in equal monthly installments from June 9, 2015 to December 9, 2015 and with respect to 2,865 shares in equal monthly installments from January 9, 2016 to August 9, 2016.
- F3As of the date of this report, the remaining ordinary shares subject to this option will vest in equal monthly installments from June 5, 2015 to December 5, 2016.